Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2021245610 - NOVEL PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF OLOPATADINE AND NEPAFENAC

Publication Number WO/2021/245610
Publication Date 09.12.2021
International Application No. PCT/IB2021/054900
International Filing Date 04.06.2021
IPC
A61K 9/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61K 9/08 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
A61K 47/36 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K 47/38 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
38Cellulose; Derivatives thereof
A61K 47/44 2017.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42107; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
A61K 31/407 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
407condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine
Applicants
  • ZENVISION PHARMA LLP [IN]/[IN]
Inventors
  • BOBBA, Sivakumar Venkata
  • MANMODE, Amit
  • SHINDE, Dhananjay
  • POPHALE, Sunil
Agents
  • MAJUMDAR, Subhatosh
  • GANGULI, Dr., Sanchita
  • SEN, Abhishek
  • VENKATESH, Mythili
  • MAJUMDAR, Amrita
  • KUNDU, Subarna
  • CHAUBEY, Priyanka
Priority Data
20192104988904.06.2020IN
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) NOVEL PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF OLOPATADINE AND NEPAFENAC
(FR) NOUVELLE COMPOSITION PHARMACEUTIQUE COMPRENANT UNE COMBINAISON D'OLOPATADINE ET DE NÉPAFÉNAC
Abstract
(EN) The present invention relates to a novel pharmaceutical composition comprising combination of Olopatadine or salt thereof and Nepafenac or salt thereof, process for preparation thereof and use thereof for the treatment of ophthalmic disorders.
(FR) La présente invention concerne une nouvelle composition pharmaceutique comprenant une combinaison d'olopatadine ou d'un sel de celle-ci et de népafénac ou d'un sel de celui-ci, son procédé de préparation et son utilisation pour le traitement de troubles ophtalmiques.
Latest bibliographic data on file with the International Bureau